-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$158.0050.36% Upside
Novo Nordisk A/S Frequently Asked Questions
-
What analysts cover Novo Nordisk A/S?
Novo Nordisk A/S has been rated by research analysts at BMO Capital, Cantor Fitzgerald, Argus Research, Goldman Sachs in the past 90 days.